If you are preparing for IVF and you have PCOS/PMOS or suspected insulin resistance, there is a number you should know before your first consultation.
In a 2026 study published in Human Reproduction examining IVF outcomes by insulin resistance status, the live birth rate for women with untreated insulin resistance was 9.6%. For insulin-sensitive women, it was 24.5%. For women with insulin resistance who received insulin-sensitizing treatment, it was 40.2%.
That is not a marginal difference. That is a fourfold difference in outcomes depending on whether insulin resistance was identified and addressed.
Most fertility clinics do not routinely test fasting insulin before IVF. This guide explains why that matters, what the research shows, and what to do about it before you start your cycle.
Why Insulin Resistance Affects IVF Outcomes
To understand the connection, you need to understand what elevated insulin does to the reproductive environment.
It disrupts ovarian response to stimulation. IVF relies on controlled ovarian hyperstimulation — using medications to stimulate the ovaries to produce multiple follicles. Women with insulin resistance often have abnormal follicle responses: either insufficient response or, in PCOS, hyperstimulation. Elevated insulin interferes with the hormonal signaling that FSH medications depend on.
It affects egg quality. The follicular environment, the fluid surrounding each developing egg, is directly influenced by metabolic health. Elevated insulin and the inflammation it drives create a less optimal environment for egg maturation. This can reduce fertilization rates and embryo quality.
It worsens endometrial receptivity. Even with a healthy embryo, implantation requires a receptive endometrium. Insulin resistance is associated with inflammation that can reduce implantation rates. This is particularly relevant in cases where fertilization and embryo development are successful, but implantation repeatedly fails.
It elevates androgens. Elevated insulin drives androgen overproduction. Excessive androgens are associated with poorer egg quality and reduced fertilization success.
It increases miscarriage risk. Research has found associations between elevated insulin and late miscarriage in women undergoing IVF, independent of other metabolic factors.
What the Research Shows
The 2026 Human Reproduction study is the most recent and one of the most comprehensive examinations of this question. But it is not the only one.
Multiple studies have shown that insulin resistance — measured by fasting insulin, HOMA-IR, or insulin-to-glucose ratios — is associated with:
- Reduced number of mature oocytes retrieved
- Lower fertilization rates
- Reduced blastocyst development rates
- Lower clinical pregnancy rates
- Higher early pregnancy loss rates
The research also consistently shows that addressing insulin resistance before or alongside IVF improves outcomes. Metformin, which reduces hepatic glucose output and improves insulin sensitivity, has been studied extensively in PCOS-related IVF cycles and has demonstrated improved live birth rates in insulin-resistant populations.
What the research does not yet have as much data on is whether lifestyle-based insulin reduction (without medication) produces the same outcome improvements — though the biological mechanism would suggest it should. The three Insara clinical studies demonstrate that fasting insulin can drop by 35-52% in eight weeks through the Low Insulin Lifestyle, which would represent a meaningful shift in the metabolic environment.
The Testing Gap
Despite the evidence, fasting insulin is not a standard pre-IVF screening test at most fertility clinics. Most protocols include:
- Hormone panels (AMH, FSH, LH, oestradiol)
- Antral follicle count via ultrasound
- Uterine assessment
- Standard blood panel including HbA1c and fasting glucose
What is typically missing: fasting insulin. A woman can have a completely normal HbA1c and fasting glucose while her fasting insulin is significantly elevated, which means the metabolic factor most directly associated with IVF outcomes can go entirely undetected.
If you are preparing for IVF, ask your fertility specialist specifically about fasting insulin testing. You can say: “I have read research connecting insulin resistance to IVF outcomes. Can we include fasting insulin in my pre-cycle workup?”
If your clinic does not offer this, you can test at home with the Insara Metabolic Kit and bring your results to your appointment.
What to Do Before Your IVF Cycle
Step 1: Test Your Fasting Insulin
This is the most important pre-IVF metabolic test that most clinics miss. A fasting insulin below 8 mIU/mL reflects optimal insulin sensitivity. Above 8 is a signal that insulin resistance is contributing to the metabolic environment your reproductive system is operating in.
The Insara Metabolic Kit measures fasting insulin alongside HbA1c, CRP, cholesterol, and triglycerides from a home finger-prick sample. Results arrive in the Insara App within 3 to 7 days.
Step 2: Start the Low Insulin Lifestyle Eight to Twelve Weeks Before Your Cycle
The clinical research shows measurable hormonal changes in eight weeks. If your IVF timeline allows it, eight to twelve weeks of consistent Low Insulin Lifestyle practice before your stimulation cycle gives the metabolic environment time to shift.
The core of this approach: replacing the foods that produce the largest insulin responses (refined starches, added sugars, non-fermented dairy, and whey protein). The Insara App walks you through this in detail.
Step 3: Have an Informed Conversation With Your Fertility Specialist
Bring your fasting insulin result to your next appointment. Ask specifically how your clinic approaches insulin resistance in PCOS patients. Ask whether Metformin or other insulin-sensitizing approaches are appropriate in your case given your result and history.
The Human Reproduction 2026 data on live birth rates, 9.6% untreated versus 40.2% treated, is a legitimate basis for this conversation.
Step 4: Protect Sleep and Manage Cortisol
Sleep deprivation and chronic stress both raise cortisol, which raises insulin. In the weeks before an IVF cycle, these inputs are particularly important. Cortisol elevation during stimulation can also affect ovarian response. Sleep protection is a genuine pre-IVF metabolic intervention.
Frequently Asked Questions
The research consistently shows associations between elevated insulin resistance markers and worse IVF outcomes, but it is not an absolute predictor. Many women with insulin resistance have successful IVF cycles. What the data shows is that addressing insulin resistance significantly improves the odds.
Yes, absolutely. Bring any fasting insulin results you have to your consultation. This is relevant clinical data for your IVF protocol. Some clinics will adjust stimulation protocols or add insulin-sensitizing support based on this information.
Eight to twelve weeks is the minimum supported by the clinical research showing meaningful changes. Longer is better if your timeline allows. Even addressing insulin resistance during the stimulation cycle itself can have some benefit, but the earlier you start, the more time the metabolic environment has to improve.
Multiple studies have shown improved outcomes with Metformin in insulin-resistant PCOS patients undergoing IVF, including reduced ovarian hyperstimulation syndrome (OHSS) risk and improved live birth rates in specific populations. This is a conversation to have with your reproductive endocrinologist based on your specific situation.
Research published in 2026 found that 30.5% of non-PCOS IVF patients had insulin resistance, and their live birth rates were significantly lower than insulin-sensitive counterparts. Insulin resistance is not exclusive to PCOS. If you have unexplained infertility, testing fasting insulin is a reasonable step regardless of whether PCOS has been diagnosed.
This is a clinical decision that depends on your specific insulin levels, your timeline, and your provider’s recommendation. The Low Insulin Lifestyle produces meaningful reductions in fasting insulin through dietary change alone. Whether that reduction is sufficient given your starting point and IVF timeline is something to evaluate with your fertility specialist.
Ovarian hyperstimulation syndrome is a potentially serious complication of IVF stimulation, particularly common in PCOS. Women with PCOS and insulin resistance may have an exaggerated ovarian response to stimulation. Addressing insulin resistance before a cycle may reduce OHSS risk. Your fertility specialist can adjust your protocol to minimize risk.
